ASCL2 and colorectal carcinoma: We identified 12 candidate SEs enriched in primary CRC over adjacent normal with high recurrence in patients, including SEs assigned to genes previously implicated in CRC including Wnt target genes MYC and ASCL2 (Figs. 1f and S2b).